FDA approved Wyost (denosumab-bbdz) and Jubbonti (denosumab-bbdz), the first FDA-approved denosumab biosimilars, to treat all indications of the reference medicines.
FDA granted the next-generation selective RET inhibitor EP0031/A400 Fast Track designation for the potential treatment of RET-fusion positive non-small cell lung cancer.
A study of over 100,000 United States veterans has found that housing for veterans with lung and colorectal cancer was associated with a survival benefit.
I recently attended a dinner party where guests lamented the use of generative AI in schools. They asked questions like, “Will kids stop learning and plug all their essay prompts into ChatGPT?”
The American Association for Cancer Research will honor the following cancer researchers and physician-scientists during the 2024 AACR annual meeting at the San Diego Convention Center April 5-10.
As part of the White House Initiative on Women’s Health Research, the Advanced Research Projects Agency for Health has established the ARPA-H Sprint for Women’s Health, which commits $100 million towards transformative research and development in women’s health (The Cancer Letter, Nov 17, 2023).
The President’s Cancer Panel has published an initial assessment of NCI’s National Cancer Plan, offering recommendations in five priority areas to accelerate progress.
Staci A. YoungJanet S. RaderLisa Sanchez-JohnsenFrancesca M. MarassiThe Medical College of Wisconsin Cancer Center has named four leaders, Staci Young, Janet Rader, Lisa Sanchez-Johnsen, and Francesca Marassi, to its team.
Allan CovensChristina TsienAllan Covens was named chair of the NRG Canadian Members Subcommittee, and Christina Tsien was named incoming vice chair of the NRG Canadian Members Subcommittee.
City of Hope established a mobile cancer prevention and screening program.
